HOXA9 and head and neck squamous cell carcinoma: HOXA9 promoter methylation is markedly higher in patients with advanced tumor stage (T), lymph node metastasis, and advanced clinical stage in patients with HNSCC, suggesting that it may be involved in the progression and metastatic potential of the disease [26].